Guidelines of the Spanish society of cardiology. Recommendations for the implantable cardioverter defibrillator;Guías de práctica clínica de la sociedad Española de Cardiología sobre el desfibrilador automático implantable

Revista Espanola de Cardiologia

Volumn 52, Issue 12, 1999, Pages 1083-1104

  Pérez Villacastín, Julián ^a   Salinas, José Ramón Carmona ^a   Madrid, Antonio Hernández ^a   Huerta, Emilio Marín ^a   Llorens, José Luis Merino ^a   Merodio, José Ormaetxe ^a   Mitjans, Ángel Moya I ^a  

^a NONE

Author keywords

Arrhythmias; Automatic implantable defibrillator

Indexed keywords

CARDIOLOGY; DEFIBRILLATOR; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SPAIN; STANDARD; SUDDEN DEATH;

ARRHYTHMIA; CARDIOLOGY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FOLLOW-UP STUDIES; HUMANS; QUALITY OF LIFE; RISK FACTORS; SPAIN;

EID: 0033254534     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (163)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gottu L, Schanble J et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303: 322-324.
2. Garratt CJ, Hotline Editorials. A new evidence base for implantable defibrillator therapy. Eur Heart J 1998; 19: 189-191.
3. Schmitt C, Alt E, Plewan A, Schomig A. Initial experience with implantation of internal cardioverter/defibrillators under local anaesthesia by electrophysiologists. Eur Heart J 1996; 17: 1.710-1.706.
4. Marín-Huerta E, Moro C, Novo L, Madrid AH, Lage J, Mestre IL et al. Implante pectoral de desfibrilador automatico por cardiólogos en un laboratorio de electrofisiología. Rev Esp Cardiol 1994; 47: 706-709.
5. Subdirección General de Prestaciones y Evaluación de Tecnología sanitarias. Dirección General de Aseguramiento y Planificación sanitaria. Ministerio de Sanidad y Consumo. Informe sobre el Desfibrilador Automático Implantable. Rev Esp Cardiol 1993; 46: 329-334.
6. Almendral J, Beiras J, Moya A, Farré J. Indicaciones actuales del desfibrilador automático implantable. En: En Asín E, Cosín J, Del Río A, editores. Normas de Actuación Clínica en Cardiología. Madrid: Sociedad Española de Cardiología, 1996; 281-293.
7. Diago JL, Madrid AH, Paylos J, Sanjuán R. Manejo del paciente con arritmias ventriculares malignas. En: Guías de Actuación clínica en Cardiología dirigidas a la Atención Primaria. Madrid: Sociedad Española de Cardiología, 1997; 207-217.
8. Villacastín J, Madrid AH, Moya A, Peinado R. Indicaciones actuales del desfibrilador automático implantable. Rev Esp Cardiol 1998; 51: 259-273.
9. Lehmann MH, Saksena S and the Naspe Policy Conference Commitee. Implantable cardioverter defibrillators in cardiovascular practice: report of the Policy Conference of the North American Society of Pacing and Electrophysiology. PACE 1991; 14: 969-979.
10. Lévy S, Hauer NW, Raviele A, Daubert JC, Campbell RW, Breithardt G. Recommendations for qualification of centres implanting and following defibrillators. Eur Heart J 1996; 17: 1.796-1.799.
11. Mahaux V, De Roy L, Ector H, Vanagt E, Vandekerckhove Y. Recommandations pour une pratique de qualité en stimulation cardiaque. J Cardiol 1996; 8: 147-152.
12. Campbell RWF, Charles R, Cowan JC, Garratt C, McComb JM, Morgan J et al. Clinical competence in electrophysiological procedures. Heart 1997; 78: 403-412.
13. Saksena S, Camm J, Bilitch M, Fisher JD, Furman S, Griffin JC et al. Clinical investigation of implantable antitachycardia devices: Report of the Policy Conference of the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1987; 10: 225-229.
14. Jordaens L, Schoenfeld P, Brugada P, De Roy L. Recommandations de bonne pratique en matière de stimulation cardiaque. Le Belgian Working group on Cardiac Pacing and Electrophysiology. J Cardiol 1997; 9: 112-114.
15. Hauer R, Derksen R, Wever EF. Can implantable cardioverter-defibrillator therapy reduce healthcare costs. Am J Cardiol 1996; 78: 134-139.
16. Valenti R, Schlapfer J, Fromer M, Fischer A, Kappenberger L. Impact of the implantable cardioverter-defibrillator on rehospitalizations. Eur Heart J 1996; 17: 1.565-1.571.
17. Wever EF, Hauer RN, Schrijvers G, Van Capelle FJ, Tijssen JG, Crijns HJ et al. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized Study. Circulation 1996; 93: 489-496.
18. Steinhaus D. Economics: selection of candidates to ICD implant. En: Santini M, editor. Proceedings, progress in Clinical Pacing 1996. Armonk: Futura Inc., 1996; 233-240.
19. Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R et al. The cost-effectiveness of Automatic Implantable Cardiac Defibrillators: Results From MADIT. Circulation 1998; 97: 2.129-2.135.
20. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Angiography). Circulation 1987; 76: 963A-977A.
21. Dolack GL, Poole JE, Kudenchuck PJ, Raitt MH, Gleva MJ, Anderson J et al. Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugs. J Cardiovasc Electrophysiol 1996; 7: 197-202.
22. Böcker D, Block M, Borggrefe M, Breithardt G. Are electrophysiological studies needed before implantable defibrillators? Eur Heart J 1997; 18: 548-551.
23. Bayés de Luna A. Utilidad de los estudios electrofisiológicos intracardíacos en la evaluación y tratamiento del superviviente de muerte súbita, Argumentos en contra. Rev Esp Cardiol 1994; 47: 356-361.
24. Villacastín JP. Utilidad de los estudios electrofisiológicos intracardíacos en la evaluación y tratamiento del superviviente de muerte súbita. Argumentos a favor. Rev Esp Cardiol 1994; 47: 350-355.
25. Wood KA, Drew BJ, Scheinman MM. Frequency of disabling symptoms in supraventricular tachycardia. Am J Cardiol 1997; 79: 145-149.
26. Guidelines for clinical intracardiac electrophysiological and ablation procedures: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on clinical intracardiac electrophysiology and catheter ablation procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1998; 26: 555-573.
27. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on pacemaker implantation). J Am Coll Cardiol 1998; 31: 1.175-1.209.
28. Almendral J, Villacastín J, Arenal A, Medina O, Peinado R, Merino JL et al. Selección de opciones terapéuticas en pacientes con taquiarritmias ventriculares sostenidas. Rev Esp Cardiol 1994; 47: 104-112.
29. Lévy S, Raviele A, Bakker P, Kuck KH, Nathan A, Hauer R. Study Group on qualifications of centres implanting ICD's, Http://www.sghms.ac.uk/depts/cardiology/esc/stud_grp.htm. 1999
30. Fitzpatrick AP, Lesh MD, Epstein LM, Lee RJ, Siu A, Merrick S et al. Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy implantable cardioverter/defibrillators. Circulation 1994; 89: 2.503-2.508.
31. Strickberger SA, Hummel JD, Daoud E, Niebauer M, Williamson BD, Man KC et al. Implantation by electrophysiologist of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems. Circulation 1994; 90: 868-872.
32. Strickberger SA, Niebauer M, Man KC, Daoud E, Williamson BD, Horwood L et al. Comparison of implantation of nonthoracotomy defibrillators in the operating room versus in the electrophysiology laboratory. Am J Cardiol 1995; 75: 225-227.
33. Pacifico A, Wheelan KR, Nasir N Jr, Well PJ, Doyle TK, Johnson SA et al. Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral sufascial position. Circulation 1997; 95: 946-950.
34. Pacifico A, Cedillo-Zalazar FR, Nasir N Jr, Doyle TK, Henry PD. Conscious sedation with combined hypnotic agents for implantation of implantable cardioverter-defibrillators. J Am Coll Cardiol 1997; 30: 769-773.
35. Geiger MJ, Wase A, Kearny MM, Brandon MJ, Kent V, Newby KH et al. Evaluation of the safety and efficacy of deep sedation for electrophysiology procedures administered in the absence of anesthesist. PACE 1997; 20: 1.808-1.814.
36. Koovoor P, Porter R, Uther JB, Ross DL. Efficacy and safety of a new protocol for continuous infusion of midazolam and fentranyl and its effects on patient distress during electrophysiological studies. PACE 1997; 20: 2.765-2.774.
37. Natale A, Kearney MM, Brandon MJ, Kent V, Wase A, Newby KH et al. Safety of nurse-administered deep sedation for defibrillator implantation in the electrophysiology laboratory. J Cardiovasc Electrophysiol 1996; 7: 301-306.
38. Goldberg JJ, Horvath G, Inbar S, Kadish AH. Utility of predischarge and one-month transvenous implantable defibrillator test. Am J Cardiol 1997; 79: 822-826.
39. a ed.). Madrid: Comunicación Estudios y Congresos S.L., 1998; 197-220.
40. Goldman BS, Newman D, Fraser J, Irwin M. Management of intracardiac device recalls: a consensus conference. Participants of the Consensus Conference. North American Society of Cardiac Pacing and Electrophysiology (NASPE). PACE 1996; 19: 7-17.
41. Weiss DN, ZIlo P, Luceri RM, Platt S, Rosenbaum M. Predischarge arrhythmia induction testing of implantable defibrillators may be unnecessary in selected cases. Am J Cardiol 1997; 80: 1.562-1.565.
42. Levy S, Hauer RNW, Raviele A, Daubert JC, Campbell RWF, Breithardt G. Recommendations for qualification of centers implantating and following defibrillators. Eur Heart J 1996; 17: 1.790-1.799.
43. Lehmann MH, Saksena S. Implantable cardioverter defibrillators in cardiovascular practice: report of the policy conference of the North American Society of Pacing and Electrophysiology 1998. Http://www.nasep.org/policy/leh91.html.
44. Engelstein ED, Zipes DP. Sudden cardiac death. En: Alexander RW, Schlant RC, Fuster V, editores. The heart, arteries and veins. Nueva York: McGraw-Hill, 1998; 1, 081-1.112.
45. a ed.). Filadelfia: W.B. Saunders Co., 1997; 742-779.
46. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98: 2.334-2.351.
47. Pratt CM, Greenway PS, Schoenfeld MH, Hibben ML, Reiffel JA. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation, 1996; 93: 519-524.
48. Torp-Pedersen C, Kober L, Elming H, Burchart H. Classification of sudden and arrhythmic death. Pacing Clin Electrophysiol 1997; 20: 2.545-2.552.
49. De Vreede Swagemakers JJM, Gorgel APM, Dubois-Arbouw van Ree JW, Daeman MJAP, Houben LGE, Wellens HJJ. Out of hospital cardiac arrest in the 90's. A population based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997; 30: 1.500-1.505.
50. Guillum RF. Sudden coronary death in the United States. Circulation 1989; 79: 756-765.
51. Myocardial Infarction Community Registry. Public Health in Europe 5. Copenhagen Regional Office for Europe: World Health Organization, 1976.
52. Cosín Aguilar J. Muerte súbita extrahospitalaria en España En: Bayés de Luna A, Brugada P, Cosín Aguilar J, Navarro López F, editores. Muerte súbita cardíaca. Barcelona: Doyma, 1991; 13-21.
53. Backer L, Eisenberg M, Fahrenbruch C, Cobb L. Public locations of cardiac arrest: implications for public access defibrillators. Circulation 1998; 97: 2.106-2.109.
54. Kerber RE, Becker LB, Bourland JD, Cummins RO, Hallstrom AP, Michos MB et al. Automatic external defibrillators for public access defibrillation: recommendations for specifying and reporting arrhythmia analysis algorithm performance, incorporating new wave forms, and enhancing safety. Circulation 1997; 95: 1.677-1.682.
55. Goldstein S, Landis J, Leighton R, Ritten G, Vasu CM, Lantis A et al. Characteristics of the resucitatcd out-of-hospital cardiac arrest victims with coronary heart disease. Circulation 1981; 64: 977-984.
56. Fahy GJ, Sgarbossa EB, Tchou PJ, Pinski SL. Hospital readmission in patients treated with tiered-therapy implantable defibrillators. Circulation 1996; 94: 1.350-1.356.
57. Arteaga WJ, Windle JR. The quality of life of patients with life-threatening arrhythmias. Arch Intern Med 1995; 155: 2.086 2.091.
58. Myerburg RJ, Castellanos A. Cardiac arrest and sudden death. En: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine, Filadelfia: WB Saunders, 1997; 742-779.
59. Freedman RA, Swerdlow CD, Soderhold-Difatte V, Mason JW, Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest. Am J Cardiol 1988; 61: 578-582.
60. Wilber DJ, Garan H, Filkelftein D, Kelly E, Newell J, McGovern D et al. Out-of-hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988; 318: 19-24.
61. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Chenarides JG. Long-term outcome of survivors of cardiac arrest whose therapy is guided by electrophysiologic testing. J Am Coll Cardiol 1992; 19: 780-788.
62. Graboys TB, Lown B, Podrid PJ, De Silva R. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 1982; 50: 437-443.
63. Eldar M, Suave MJ, Scheinman MM. Electrophysiologic testing and follow-up of patients with aborted sudden death. J Am Coll Cardiol 1987; 10: 291-298.
64. Furukawa T, Rozanski J, Nogami A, Moroe K, Gosselin A, Lister JW. Time dependent risk of and predictors for cardiac arrest recurrence in survivors of out-of-hospital cardiac arrest with chronic coronary artery disease. Circulation 1989; 80: 599-608.
65. Kehoe R, Tommasco C, Zheutleir T. Factors determining programmed stimulation responses and long-term arrhythmic outcome in survivors of ventricular fibrillation with ischemic heart disease. Am Heart J 1988; 116: 355-363.
66. Skale BT, Miles WM, Heger JJ, Zipes DP, Prystowsky EN. Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring. Am J Cardiol 1986; 57: 113-119.
67. Ruskin JN, DiMarco JP, Garan H. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med 1980; 303: 607-613.
68. Morady F, Scheinman MM, Hess DS, Sung RJ, Shen E, Shapiro W. Electrophysiologic testing in the management of survivors of a out-of-hospital cardiac arrest. Am J Cardiol 1983; 51: 85-89.
69. Benditt DG, Benson DW, Klein GJ, Pritzer MR, Kriett JM. Anderson RW. Prevention of recurrent sudden cardiac arrest: Role of provocative electropharmacologic testing. J. Am Coll Cardiol 1983; 2: 418-425.
70. Poole JE, Mathisen TL, Kudenchuk PJ, McAnulty JH, Serdlow CD, Bardy GH et al. Long term outcome in patients who survive out of hospital ventricular fibrillation and undergo eletrophysiologic studies: evaluation by electrophysiologic subgroups. J Am Coll Cardiol 1990; 16: 657-665.
71. Roy D, Waxman HL, Kienzle MG, Buxton AE, Marchlinski FE, Josephson ME. Clinical characteristics and long term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing. Am J Cardiol 1983; 52: 969-974.
72. Moro C, Almendral J, Fiol M, Cosín J, Guindo J, Marrugat J et al. Randomized trial comparing empiric amiodarone versus guided pharmacologic therapy for malignant ventricular arrhythmias (Spanish trial on sudden death) [resumen]. Circulation 1991; 84: 126.
73. The CASCADE investigators. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study). Am J Cardiol 1993; 72: 280-287.
74. Powell AC, Fuchs T, Finkelstein D, Garan H, Cannom DS. McGovern BA et al. Influence of implantable cardioverter defibrillators on the long-lerm prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993; 88: 1.083-1.092.
75. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994; 127: 1.139-1.144.
76. Wever EF, Hauer RN, Van Capelle FJ, Tijssen JG, Crijns HJ, Algra A et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995; 91: 2.195-2.203.
77. Böcker D, Haverkamp W, Block M, Borggrefe M, Hammel D, Breithardt G. Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation 1996; 94: 151-157.
78. The Antiarrhythmic Versus Implantable Defibrillators (Avid) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resucitated from Nearfatal ventricular arrhythmias. N Engl J Med 1997; 337: 1.576-1.593.
79. Roy D, Talajic M, Tang A, Dubuc M, Gardner M, Thibault B et al. Mode of death in the Canadian Implantable Defibrillator Study (CIDS). Circulation 1998; 17 (Supl): 2.606.
80. Kelly P, Ruskin JN, Vlahakes GJ, Buckley MJ, Freeman CS, Garan H. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 1990; 15: 267-273.
81. Every NR, Fahrenbruch CE, Hallstrom AP, Weaver DW, Cobb LA. Influence of coronary bypass surgery on subsequent outcome of patients resucitated from out-of-hospital cardiac arrest. J Am Coll Cardiol 1992; 19: 1.435-1.439.
82. Manolis AS, Rastegar H, Estes IM. Effects of coronary bypass grafting on ventricular arrhythmias: results with electrophysiological testing and long term follow up. PACE 1993; 16: 984-991.
83. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias and sudden death in patients with vasospastic angina. Circulation 1987; 75: 1.110-1.116.
84. MacAlpin RN. Cardiac arrest and sudden unexpected death in variant angina: complications of coronary spasm that can occur in the absence of severe organic coronary stenosis. Am Heart J 1993; 125: 1.011-1.017.
85. Lacroix D, Kacet S, Lekieffre J. Vasospastic angina without flow-limiting coronary lesions as a cause for aborted sudden death. Int J Cardiol 1994; 43: 247-249.
86. Fuertes J, Gallego P, Peinado R, Merino JL. Implantable cardioverter defibrillator as therapeutic option for sudden cardiac death secondary to severe coronary vasospasm. Int J Cardiol 1998; 63: 181-183.
87. Chevalier P, Dacosta A, Defaye P, Chalvidan T, Bonnefoy E, Kirkorian G et al. Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. J Am Coll Cardiol 1998; 31: 57-61.
88. Myerburg RJ, Conde CA, Sung RJ, Mayorga-Cortes A, Mallon SM, Sheps DS et al. Clinical, electrophysiologic and hemodynamic profile of patients resucitated from pre-hospital cardiac arrest. Am J Med 1980; 68: 568-576.
89. Priori SG, Borggrefe M, Camm AJ, Hauer RNW, Klein H, Kuck KH et al. Role of programmed electrical stimulation in the identification of the effective pharmacologic therapy in patients with idiopathic ventricular fibrillation [resumen]. Circulation 1995; 92: 97.
90. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Survivors of out-of Hospital cardiac arrest with apparently normal heart. Circulation 1997; 95: 265-272.
91. MIDAS investigators. Multicenter Implantable Defibrillator And Survival (MIDAS) Study: Survival and incidence of appropriate shock in patients with no structural heart disease [resumen]. Circulation 1992; 86 (Supl 1): 656.
92. Priori SG, Borggrefe M, Camm AJ, Hauer RNW, Klein H, Kuck KH et al. on behalf of UCARE. Role of the implantable defibrillator in patients with idiopathic ventricular fibrillation: data from the UCARE international registry [resumen]. Pacing Clin Electrophysiol 1995; 18: 799.
93. Belhassen B, Viskin S. Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol 1993; 4: 356-368.
94. Wever EF, Hauer RN, Oomen A, Peters R, Bakker PF, Robles de Medina EO. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 1993; 88: 1.021-1.029.
95. Brugada P, Brugada J, Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992; 20: 1.391-1.396.
96. Brugada J, Brugada R, Brugada P. Right bundle branch block and ST segment elevation in leads V1-V3: a marker for sudden death in patients without demonstrable structural heart disease [resumen].Circulation 1997; 96 (Supl 1): 151.
97. Brugada J, Brugada R, Brugada P. Right bundle-branch block, and ST-segment elevation in leads V1 trhiugh V3. A marker for sudden death in patients without demosntrable structural heart disease. Circulation 1998; 97: 457-460.
98. Brugada P, Talajic M, Smeets J, Mulleneers R, Wellens HJJ. The value of the clinical history to asses prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Eur Heart J 1989; 10: 743-749.
99. Mason JW, for the ESVEM investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias, N Engl J Med 1993; 329: 452-458.
100. Mason JW, for the ESVEM investigators. A comparison of electrophysiologic testing with holter monitoring to predict antiarrhythmic drug efficacy for ventricular tachyarrhythmias. N Engl J Med 1993; 329: 445-451.
101. Spielman SR, Schwartz JS, McCarthy DM, Horowitz LN, Greenspan AM, Sadowski LM et al. Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: a discriminant analysis. J Am Coll Cardiol 1983; 1: 401-408.
102. Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM. Recurrent sustained ventricular tachycardia. 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 1978; 58: 986-997.
103. Mason JW, Winkle RA. Accuracy of the ventricular tachycardia induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs. N Engl J Med 1980; 303; 1.073-1.077.
104. Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic sustained ventricular tachyarrhythmias. N Engl J Med 1992; 327: 987-992.
105. Morady F, Harvey M, Kalbfleisch SJ, El-Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993; 87: 363-372.
106. Stevenson W, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993; 88: 1.647-1.670.
107. Kim YH, Sosa-Suarez G, Trouton TG, O'Nunain SS, Osswald S, McGovern BA. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation 1994; 89: 1.094-1.102.
108. Rothman S, Hsia H, Cossu S, Chmielewski L, Buxton A, Miller J. Radiofrequency catheter ablation of postinfarction ventricular tachycardia. Long-term success and the Significance of inducible nonclinical arrhythmias. Circulation 1997; 96: 3.499-3.508.
109. Rastegar H, Link MS, Foote CB, Wang PJ, Manolis AS, Mark Estes III NA. Perioperative and long-term results with mapping-guided subendocardial resection and left ventricular endoaneurysmorrhaphy. Circulation 1996; 94: 1.041 -1.048.
110. Bueno H, Almendral J, Albertos J, Arenal A, Pérez Villacastín J, Pastor A et al. Tratamiento quirúrgico de las taquicardias ventriculares sostenidas. Resultados a corto y medio plazo en la «era» del desfibrilador implantable y del trasplante cardíaco. Rev Esp Cardiol 1994; 47: 227-238.
111. Garan H, Nguyen K, Mc Govern B, Buckley M, Ruskin JN. Perioperative and long-term results after electrophysiologically directed ventricular surgery for recurrent ventricular tachycardia. J Am Coll Cardiol 1986; 8: 201-209.
112. Blanck Z, Dhala A, Deshpande S, Sra J, Mazayeri M, Akhtar M. Bundle branch reentrant ventricular tachycardia: cumulative experience in 48 patients. J Cardiovasc Electrophysiol 1993; 4: 253-262.
113. Tchou P, Mehdirad AA. Bundle branch reentry ventricular tachycardia. PACE 1995; 18: 1.427-1.437.
114. Merino JL, Carmona JR, Fernández-Lozano I, Peinado R, Basterra N, Sobrino JA. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. Circulation 1998; 98: 541-546.
115. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical. Holter, hemodynamic, and electrophysiologic findings. Circulation 1992; 86: 730-740.
116. Borgreffe M, Chen X, Block M, Haverkamp G, Hindrick G, Shenasa M et al. The role of ICD in patients with dilated and hypertrophic cardiomyopathy. PACE 1992; 15: 616-626.
117. Stewart JT, McKenna WJ. Arrhythmias in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 1992; 3: 516-424.
118. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992; 86: 29-37.
119. Haverkamp W, Borggrefe M, Chen X, Wichter T, Hindricks G, Willems S et al. Radiofrequency catheter ablation in patients with sustained ventricular tachycardia and arrhythmogenic right ventricular disease. Circulation 1993; 8: 353.
120. Wichter T, Block M, Bocker D, Hammel D, Scheld H, Breithard G. Cardioverter defibrillator therapy in high risk patients with arrhythmogenic right ventricular cardiomyopathy: special aspects for implantation and follow-up results. Circulation 1993; 88: 156.
121. Klein LS, Shin HT, Hackett FK, Zipes DP, Miles WM. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992; 85: 1.666-1.674.
122. Nakagawa H, Beckman KJ, McClelland JH, Wang X, Arruda M, Santoro I et al. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation 1993; 88: 2.607-2.617.
123. Coggins DL, Lee RJ, Sweeney J, Chein WW, VanHare G, Epstein L et al. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol 1994; 23: 1.333-1.341.
124. Wen MS, Yen SJ, Wang CC, Lin FC, Chen IC, Wu D, Radiofrequency ablation therapy in idiopathic left ventricular tachycardia with no obvious structural heart disease. Circulation 1994; 89: 1.690-1.696.
125. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991; 84: 1.136-1.144.
126. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of the congenital long QT syndrome: a worldwide report. Circulation 1991; 84: 503-511.
127. Garson A, Dick M, Fournier A, Gillette PC, Hamilton R, Kugler JD et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993; 87: 1.866-1.872.
128. Moss AJ. Management of patients with the hereditary long QT syndrome. J Cardiovasc Electrophysiol 1998; 9: 668-674.
129. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996; 78: 703-706.
130. Silka MJ, Kron J, Dunnigan A. Dick M. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. Circulation 1993; 87: 800-807.
131. DiMarco JP, Garan H, Harthorne JW, Ruskin JN. Intracardiac electrophysiologic techniques in recurrent syncope of unknown origin. Ann Intern Med 1981; 95: 542-548.
132. Morady F, Shen E, Schwartz A. Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiological testing. J Am Coll Cardiol 1983; 2: 1.053-1.059.
133. Olshansky B, Mazuz M, Martins JB. Significance of inducible tachycardia in patients with syncope of unknown origin: a longterm follow-up. J Am Coll Cardiol 1985; 5: 216-223.
134. García Civera R, Sanjuán R, Morell S. Estudios electrofisiológicos en pacientes con síncope de causa desconocida. Rev Esp Cardiol 1985; 38: 190-197.
135. Bass EB, Elson JJ, Fogoros RN. Long term prognosis of patients undergoing electrophysiologyc studies for syncope of unknown origin. Am J Cardiol 1988; 62: 1.186-1.191.
136. Knight B, Strikberger A, Daoud M, Goyal R, Souza J, Zivin A et al. Outcome of patients with non ischemic dilated cardiomyopathy and unexplained syncope treated with an implantable cardioverter defibrillator [resumen]. Circulation 1997; 96 (Supl 1): 708.
137. ACC/AHA Task Force Report. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. J Am Coll Cardiol 1995; 26: 555-573.
138. McAnulty JH, Rahimtola SH, Murphy E, DeMots H, Ritzman L. Kanasek PE et al. Natural history of high-risk bundle-branch block: final report of a prospective study. N Engl J Med 1982; 307: 137-143.
139. Militianu A, Salacata A, Seibert K, Kehoe R, Baga JJ, Meissner MD et al. Implantable cardioverter defibrillalor utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol 1997; 10: 1.087-1.097.
140. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1.933-1.940.
141. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997; 337: 1.569-1.575.
142. Buxton AE, Usher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN et al. Prevention of suden death in patients with coronary artery disease: the Multicenter Unsustained Tachycardia Trial (MUSTT). Progress Cardiovasc Dis 1993; 36: 215-226.
143. Aligns M, Wilde A, «Bruguda» syndrome. Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99: 666-673.
144. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-785.
145. Reid PR, Mirowski M, Mower MM. Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death. Am J Cardiol 1983; 51: 1.608-1.613.
146. Böcker D, Block M, Isbruch F. Benefits of treatment with implantable cardioverer-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 1995; 73: 158-163.
147. Winkle RA, Mead RH, Ruder MA, Guadiani VA, Smith NA, Buch WS et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 16: 1.353-1.361.
148. Fogoros RN, Elson JJ, Bonnet CA. Survival of patients who have received appropiate shocks from their implantable defibrillators. PACE 1991; 94: 1.842-1.845.
149. Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation 1993; 87: 1.880-1.888.
150. Kou WH, Calkins H, Lewis RR, Bolling SF, Kirsch MM, Langberg JJ et al. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med 1991; 115: 942-945.
151. Grimm W, Flores BF, Marchlinsky FE. Symptoms and electrocardiographycally documented rhythm preceeding spontaneous shocks in patients with implantable cardioverter-defibrillator. Am J Cardiol 1993; 71: 1.415-1.418.
152. Steinbach KK, Merl O, Frohner K, Hief C, Nurnmerg M, Kaltenbrunner W et al. Hemodynamics during ventricular tachyarrhythmias. Am Heart J 1994; 127: 1.102-1.106.
153. Anderson MH, Katritsis D, Gibson SA, Ross DJ, Pickering A. Automobile driving and ventricular arrhythmias: implications of a study of motor performance during rapid ventricular pacing [resumen]. Circulation 1992; 86 (Supl 1 ): 313.
154. Steinbeck G, Dorwarth U, Mattke S, Hoffmann E, Markewitz A, Kaulbach H et al. Hemodynamic deterioration during ICD implant: predictors of high-risk patients. Am Heart J 1994; 127: 1.064-1.067.
155. Anderson MH, Camm AJ, Legal and ethical aspects of driving and working in patientes with an implantable cardioverter defibrillator. Am Heart J 1994; 127: 1.185-1.193.
156. Curtis AB, Conti JB, Tucker KJ, Kubilis PS, Reilly RE. Woodard DA. Motor vehicle accidents in patients with an implantable cardioverter-defibrillator. J Am Coll Cardiol 1995; 26: 180-184.
157. Lüderitz B, Jung W. Driving restrictions after cardioverter/defibrillator implantation. En: Oto A, editor. Practice and progress in cardiac pacing and electrophysiology. Dordrecht: Kluwer Academics, 1996; 373-381.
158. Lüderitz B, Jung W. Driving behavior after cardioverter-defibrillator implantation in Europe. New Trends Arrhyth 1996; 11: 53-57.
159. Lüderitz B, Jung W. Fitness to drive after implantation of cardioverter-defibrillator. Criteria for medical judging of fitness to drive in Europe. Dtsch Med Wschr 1996; 121: 119-123.
160. Jung W, Lüderitz B. European policy on driving for patients with implantable cardioveter-defibrillators. PACE 1996; 19: 981-984.
161. Jung W, Lüderitz B. Quality of life and driving in recipients of the implantable cardioverter-defibrillator. Am J Cardiol 1996; 78 (Sup 5A): 5l-56.
162. Jung W, Anderson M, Camm AJ, Jordaens L, Petch MC, Rosenqvist M et al. Recommendations for driving of patients with implantable cardioverter defibrillators. Eur Heart J 1997; 18: 1.210-1.219.
163. Bänsen D, Brunn J, Castrucci M, Weber M, Gietzen F, Borggrefe M et al. Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol 1998; 31: 608-615.